Skip to main content

Lilly's Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds

By Reuters  
   November 28, 2023

Patients taking Mounjaro were 76% more likely to lose at least 5% of their body weight, more than twice as likely to lose at least 10%, and more than three times as likely to lose at least 15%, compared to patients taking Ozempic.

Full story


Get the latest on healthcare leadership in your inbox.